These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 12816345)
1. Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia--genetic short limbed dwarfism. Aviezer D; Golembo M; Yayon A Curr Drug Targets; 2003 Jul; 4(5):353-65. PubMed ID: 12816345 [TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. Webster MK; Donoghue DJ EMBO J; 1996 Feb; 15(3):520-7. PubMed ID: 8599935 [TBL] [Abstract][Full Text] [Related]
3. Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia. Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A Horm Res; 1996; 45(1-2):108-10. PubMed ID: 8742128 [TBL] [Abstract][Full Text] [Related]
4. Achondroplasia: from genotype to phenotype. Richette P; Bardin T; Stheneur C Joint Bone Spine; 2008 Mar; 75(2):125-30. PubMed ID: 17950653 [TBL] [Abstract][Full Text] [Related]
5. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Wang Y; Spatz MK; Kannan K; Hayk H; Avivi A; Gorivodsky M; Pines M; Yayon A; Lonai P; Givol D Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4455-60. PubMed ID: 10200283 [TBL] [Abstract][Full Text] [Related]
6. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Li C; Chen L; Iwata T; Kitagawa M; Fu XY; Deng CX Hum Mol Genet; 1999 Jan; 8(1):35-44. PubMed ID: 9887329 [TBL] [Abstract][Full Text] [Related]
7. Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Ikegawa S; Fukushima Y; Isomura M; Takada F; Nakamura Y Hum Genet; 1995 Sep; 96(3):309-11. PubMed ID: 7649548 [TBL] [Abstract][Full Text] [Related]
8. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Naski MC; Colvin JS; Coffin JD; Ornitz DM Development; 1998 Dec; 125(24):4977-88. PubMed ID: 9811582 [TBL] [Abstract][Full Text] [Related]
9. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A Nature; 1994 Sep; 371(6494):252-4. PubMed ID: 8078586 [TBL] [Abstract][Full Text] [Related]
10. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P Am J Med Genet; 1996 May; 63(1):148-54. PubMed ID: 8723101 [TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Murakami S; Balmes G; McKinney S; Zhang Z; Givol D; de Crombrugghe B Genes Dev; 2004 Feb; 18(3):290-305. PubMed ID: 14871928 [TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor]. van Ravenswaaij-Arts CM; Losekoot M Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167 [TBL] [Abstract][Full Text] [Related]
13. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Vajo Z; Francomano CA; Wilkin DJ Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568 [TBL] [Abstract][Full Text] [Related]
14. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene. Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294 [TBL] [Abstract][Full Text] [Related]
15. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Naski MC; Wang Q; Xu J; Ornitz DM Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234 [TBL] [Abstract][Full Text] [Related]
16. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Iwata T; Li CL; Deng CX; Francomano CA Hum Mol Genet; 2001 Jun; 10(12):1255-64. PubMed ID: 11406607 [TBL] [Abstract][Full Text] [Related]
17. A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. Chen L; Li C; Qiao W; Xu X; Deng C Hum Mol Genet; 2001 Mar; 10(5):457-65. PubMed ID: 11181569 [TBL] [Abstract][Full Text] [Related]
18. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Shiang R; Thompson LM; Zhu YZ; Church DM; Fielder TJ; Bocian M; Winokur ST; Wasmuth JJ Cell; 1994 Jul; 78(2):335-42. PubMed ID: 7913883 [TBL] [Abstract][Full Text] [Related]
19. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Bellus GA; Hefferon TW; Ortiz de Luna RI; Hecht JT; Horton WA; Machado M; Kaitila I; McIntosh I; Francomano CA Am J Hum Genet; 1995 Feb; 56(2):368-73. PubMed ID: 7847369 [TBL] [Abstract][Full Text] [Related]
20. Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells. Thompson LM; Raffioni S; Wasmuth JJ; Bradshaw RA Mol Cell Biol; 1997 Jul; 17(7):4169-77. PubMed ID: 9199352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]